Quick Answer
Aterian, Inc. reported Research And Development Expense of $0.00 for the year ending 2024.
- Aterian, Inc. showed a decrease of -100.0% in Research And Development Expense from 2023 to 2024.
- This data is from Aterian, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $897.0 thousand | Q3 2018: $790.0 thousand | Q1 2019: $1.16 million | Q2 2019: $3.34 million | Q3 2019: $3.23 million | Q1 2020: $2.28 million | Q2 2020: $2.45 million | Q3 2020: $1.85 million | Q1 2021: $2.12 million | Q2 2021: $2.32 million | Q3 2021: $2.77 million | Q1 2022: $1.14 million | Q2 2022: $1.73 million | Q3 2022: $1.71 million | Q1 2023: $1.25 million | Q2 2023: $1.71 million | Q3 2023: $852.0 thousand | Q1 2024: $0.00 | Q2 2024: $0.00 | Q3 2024: $0.00.
- Over the full 7 years of available data (2018 to 2024), Aterian, Inc.'s Research And Development Expense has declined by 100.0%.
- Historical annual values: Fiscal year 2024: $0.00 | Fiscal year 2023: $4.62 million | Fiscal year 2022: $6.01 million | Fiscal year 2021: $9.84 million | Fiscal year 2020: $8.13 million | Fiscal year 2019: $10.66 million | Fiscal year 2018: $3.66 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: